- Home
- WGRX vs POAS Comparison
WGRX vs POAS Comparison
Compare WGRX & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WGRX | POAS |
|---|---|---|
| Founded | 2022 | 2017 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6M | 22.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WGRX | POAS |
|---|---|---|
| Price | $0.13 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 10.9M | 235.6K |
| Earning Date | 05-11-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.10 | $0.53 |
| 52 Week High | $7.04 | $7.40 |
Technical Indicators
Market Signals| Indicator | WGRX | POAS |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 48.64 |
| Support Level | $0.10 | $1.40 |
| Resistance Level | $0.17 | $2.21 |
| Average True Range (ATR) | 0.02 | 0.16 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 46.45 | 33.33 |
Price Performance
Historical ComparisonAbout WGRX Wellgistics Health Inc.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.